Interpace Biosciences Inc EV/EBITDA
¿Qué es el EV/EBITDA de Interpace Biosciences Inc?
El EV/EBITDA de Interpace Biosciences Inc es N/A
¿Cuál es la definición de EV/EBITDA?
EV / EBITDA es el valor de la empresa dividido por las ganancias antes de intereses, impuestos, depreciación y amortización. Es una medida de cuál cara es una acción y es más frecuentemente válida para comparaciones entre compañías que la relación precio / ganancias. Mide el precio (en forma de valor empresarial) que un inversionista paga en beneficio del flujo de caja de la compañía (en forma de EBITDA).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA de compañías en Sector Health Care en NASDAQ en comparadas con Interpace Biosciences Inc
¿Qué hace Interpace Biosciences Inc?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Empresas con ev/ebitda similar a Interpace Biosciences Inc
- Flying Service tiene EV/EBITDA de N/A
- Cinda International tiene EV/EBITDA de N/A
- Applied Molecular Transport tiene EV/EBITDA de N/A
- BAIC Motor tiene EV/EBITDA de N/A
- Dickson Concepts (International) tiene EV/EBITDA de N/A
- JB&ZJMY Co tiene EV/EBITDA de N/A
- Interpace Biosciences Inc tiene EV/EBITDA de N/A
- Adial Pharmaceuticals tiene EV/EBITDA de N/A
- PlantX Life tiene EV/EBITDA de N/A
- Axios Mobile Assets tiene EV/EBITDA de N/A
- Amira Nature Foods tiene EV/EBITDA de N/A
- Chromatic India tiene EV/EBITDA de N/A
- Mvp Hldgs Inc New tiene EV/EBITDA de N/A